Skip to content

A post market clinical follow-up study with the short stem uncemented endoprosthesis (optimys )

A post market clinical follow-up study with the short stem uncemented endoprosthesis (optimys )

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00014711
Enrollment
150
Registered
2018-05-07
Start date
2012-06-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M16.1 M16.7

Interventions

Group 1: Total hip arthroplasty using an optimys stem. Clinical and radiological follow-up after 6 weeks, 6, 12, 24 months, 5 and 10 years. Sub-group: Additional measurement of offset and leg lengt

Sponsors

Mathys Orthopädie GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patient shall: • suffer from primary or secondary coxarthrosis. One or more of the following pathologies/symptoms: coxarthrosis, dysplastic coxarthrosis, rheumatoid arthritis, necrosis of the head of the femur or posttraumatic coxarthrosis. • Be ready to participate in the follow-up examinations mentioned above • Be between 18 and 85 years old at the time of inclusion • Be a candidate for a primary implantation of a hip endoprosthesis • Be expected to recover completely Additional inclusion criteria for sub-group: • Implantation of a RM Pressfit vitamys Cup • Unilateral THA with healthy contralateral hip • X-ray must be analyzable

Exclusion criteria

Exclusion criteria: Patient may not: • Participate simultaneously in another clinical study or documentation with other orthopaedic implants of competitors. • Offer no guarantee for regular follow-up controls • Suffer from the exclusion criteria: sepsis or malignant tumours. • Have an ASA Classification > 3. • Have a revision surgery

Design outcomes

Primary

MeasureTime frame
Harris Hip Score after 2 years is defined as Primary endpoint. However, the score is recorded in every follow-up visit.

Secondary

MeasureTime frame
i) EBRA Analysis ii) Detection of early loosening iii) Collection of complications. Retrospective EBRA Analysis is carried out after 2 and 5 years. Early loosening and complications are recorded at every follow-up visit. iv) Sub-group: reconstruction of offset and leg length (parameter measured on the first postoperative X-ray)

Countries

Austria, Germany

Contacts

Public ContactNatividad Zeleny

Mathys Mathys Orthopädie GmbH

natividad.zeleny@mathysmedical.com+49 (0)1705722702

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026